IRIS Accounts Production v25.1.3.33 04792968 director 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary A 1.00000 Ordinary C & D 1.00000 Ordinary E 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh047929682024-03-31047929682025-03-31047929682024-04-012025-03-31047929682023-03-31047929682023-04-012024-03-31047929682024-03-3104792968ns15:EnglandWales2024-04-012025-03-3104792968ns14:PoundSterling2024-04-012025-03-3104792968ns10:Director12024-04-012025-03-3104792968ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3104792968ns10:SmallEntities2024-04-012025-03-3104792968ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3104792968ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3104792968ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3104792968ns10:FullAccounts2024-04-012025-03-3104792968ns10:OrdinaryShareClass12024-04-012025-03-3104792968ns10:OrdinaryShareClass22024-04-012025-03-3104792968ns10:OrdinaryShareClass32024-04-012025-03-3104792968ns10:CompanySecretary12024-04-012025-03-3104792968ns10:RegisteredOffice2024-04-012025-03-3104792968ns5:CurrentFinancialInstruments2025-03-3104792968ns5:CurrentFinancialInstruments2024-03-3104792968ns5:Non-currentFinancialInstruments2025-03-3104792968ns5:Non-currentFinancialInstruments2024-03-3104792968ns5:ShareCapital2025-03-3104792968ns5:ShareCapital2024-03-3104792968ns5:CapitalRedemptionReserve2025-03-3104792968ns5:CapitalRedemptionReserve2024-03-3104792968ns5:RetainedEarningsAccumulatedLosses2025-03-3104792968ns5:RetainedEarningsAccumulatedLosses2024-03-3104792968ns5:PlantMachinery2024-04-012025-03-3104792968ns5:FurnitureFittings2024-04-012025-03-3104792968ns5:ComputerEquipment2024-04-012025-03-3104792968ns5:PlantMachinery2024-03-3104792968ns5:FurnitureFittings2024-03-3104792968ns5:ComputerEquipment2024-03-3104792968ns5:PlantMachinery2025-03-3104792968ns5:FurnitureFittings2025-03-3104792968ns5:ComputerEquipment2025-03-3104792968ns5:PlantMachinery2024-03-3104792968ns5:FurnitureFittings2024-03-3104792968ns5:ComputerEquipment2024-03-3104792968ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3104792968ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3104792968ns10:OrdinaryShareClass12025-03-3104792968ns10:OrdinaryShareClass22025-03-3104792968ns10:OrdinaryShareClass32025-03-31
REGISTERED NUMBER: 04792968 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

MEDIFINANCE LIMITED

MEDIFINANCE LIMITED (REGISTERED NUMBER: 04792968)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MEDIFINANCE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: R Cox





SECRETARY: R Cox





REGISTERED OFFICE: 2 Manor Farm Court,
Old Wolverton Road,
Milton Keynes
Buckinghamshire
MK12 5NN





REGISTERED NUMBER: 04792968 (England and Wales)





ACCOUNTANTS: Ad Valorem Accountancy Services Limited
Chartered Certified Accountants
2 Manor Farm Court
Old Wolverton Road
Old Wolverton
Buckinghamshire
MK12 5NN

MEDIFINANCE LIMITED (REGISTERED NUMBER: 04792968)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £ £ £
FIXED ASSETS
Tangible assets 4 1,415 1,324

CURRENT ASSETS
Stocks 22,750 26,784
Debtors 5 58,885 68,227
Cash at bank and in hand 104,184 92,436
185,819 187,447
CREDITORS
Amounts falling due within one year 6 82,189 94,355
NET CURRENT ASSETS 103,630 93,092
TOTAL ASSETS LESS CURRENT
LIABILITIES

105,045

94,416

CREDITORS
Amounts falling due after more than one
year

7

7,917

18,493
NET ASSETS 97,128 75,923

CAPITAL AND RESERVES
Called up share capital 8 148 148
Capital redemption reserve 52 52
Retained earnings 96,928 75,723
SHAREHOLDERS' FUNDS 97,128 75,923

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDIFINANCE LIMITED (REGISTERED NUMBER: 04792968)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 May 2025 and were signed by:





R Cox - Director


MEDIFINANCE LIMITED (REGISTERED NUMBER: 04792968)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Medifinance Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

STOCKS
Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

TAXATION
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

MEDIFINANCE LIMITED (REGISTERED NUMBER: 04792968)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£ £ £ £
COST
At 1 April 2024 8,035 1,709 5,315 15,059
Additions - - 650 650
Disposals (8,035 ) (517 ) (4,510 ) (13,062 )
At 31 March 2025 - 1,192 1,455 2,647
DEPRECIATION
At 1 April 2024 8,035 736 4,964 13,735
Charge for year - 238 321 559
Eliminated on disposal (8,035 ) (517 ) (4,510 ) (13,062 )
At 31 March 2025 - 457 775 1,232
NET BOOK VALUE
At 31 March 2025 - 735 680 1,415
At 31 March 2024 - 973 351 1,324

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 45,387 66,588
Other debtors 13,498 1,639
58,885 68,227

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Bank loans and overdrafts 10,366 9,944
Trade creditors 54,036 60,398
Taxation and social security 16,235 21,646
Other creditors 1,552 2,367
82,189 94,355

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£ £
Bank loans 7,917 18,493

MEDIFINANCE LIMITED (REGISTERED NUMBER: 04792968)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £ £
58 Ordinary A 1 58 58
40 Ordinary C & D 1 40 40
50 Ordinary E 1 50 50
148 148